Synthesize Bio develops generative AI models that accelerate biomedical innovation. Our generative genomics platform is a new paradigm for drug development that redefines what’s possible. 

GEM-1, our flagship foundation model, generates high-fidelity bulk and single-cell RNA-seq data from experimental descriptions with lab-level accuracy. We empower researchers to test hypotheses and answer biological questions with unprecedented speed, especially when experimental data is limited.

Our models and platform are designed by scientists for scientists. Our user-friendly web platform and API access allow scientists to easily generate the data they need with GEM-1 and integrate those AI data with the vast repository of pre-processed public data that we provide – or their own experimental data. 

We are creating a future where the only limit on running experiments is a scientist's imagination.